Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

DEC 18, 2014 - Yahoo! News

A Must Read - Share

Exclusive: Amgen's new leukemia drug to carry $178,000 price tag

By Ransdell Pierson (Reuters) - Amgen Inc on Wednesday said its new type of treatment for a deadly form of leukemia would cost about $178,000 when it becomes available on Thursday, which would make it one of the world's most expensive cancer drugs. Company spokeswoman Danielle Bertrand said the price for the infused medicine, called Blincyto, would reflect two courses ...

Tags: Exclusive: Amgen's new leukemia drug to carry $178,000 price tag,  Amgen Latest News

DEC 17, 2014 - Yahoo! News

A Must Read - Share

Amgen's new leukemia drug to carry $178,000 price tag

By Ransdell Pierson (Reuters) - Amgen Inc on Wednesday said its new type of treatment for a deadly form of leukemia would cost about $178,000 when it becomes available on Thursday, which would make it one of the world's most expensive cancer drugs. Company spokeswoman Danielle Bertrand said the price for the infused medicine, called Blincyto, would reflect two courses ...

Tags: Amgen's new leukemia drug to carry $178,000 price tag,  Amgen Latest News

DEC 08, 2014 - Reuters

A Must Read - Share

Novartis copy of Amgen biotech drug shows similar efficacy-study

ZURICH (Reuters) - Novartis said its copycat version of Amgen's Neupogen for patients with low white blood cell counts works as well as the original drug in a late-stage trial.

Tags: Novartis copy of Amgen biotech drug shows similar efficacy-study,  Amgen Latest News

DEC 07, 2014 - Yahoo! News

A Must Read - Share

Addition of Amgen drug boosts benefits in relapsed myeloma: study

By Bill Berkrot (Reuters) - Significantly more patients with relapsed multiple myeloma responded to a three-drug regimen including Amgen Inc's Kyprolis than those who got the standard two-drug treatment, according to results from a late-stage trial. Patients with the blood cancer who received the Kyprolis regimen for 18 months also had a longer duration of response and reported better health-related ...

Tags: Addition of Amgen drug boosts benefits in relapsed myeloma: study,  Amgen Latest News

DEC 05, 2014 - Yahoo! News

A Must Read - Share

Sandoz loses bid to shield psoriasis drug

By Brendan Pierson (Reuters) - The top U.S. patent appeals court has upheld the dismissal of a lawsuit brought by Sandoz Inc that sought to shield its planned version of Amgen Inc's psoriasis and arthritis drug Enbrel from patent lawsuits. The ruling, handed down Friday by Judge Richard Taranto of the U.S. Court of Appeals for the Federal Circuit, does ...

Tags: Sandoz loses bid to shield psoriasis drug,  Amgen Latest News